Work

GV-1001, an injectable telomerase peptide vaccine for the treatment of solid cancers.

Year: 2007

Type: article

Source: PubMed

Authors: Pilar Nava-Parada, Leisha A Emens

Institutions: Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2290984120

FWCI: 1.08

Cites:

Cited by: 28

Related to: 10